Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Claya vs LIV by WellNow

Claya
Graded #264

Lower grade

vs+0.10000000000000142
LIV by WellNow
Graded #262

Higher grade

The verdict

LIV by WellNow takes it — 62.9/100 to 62.8/100, but only just.

LIV by WellNow grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. LIV by WellNow is the telehealth weight-management arm of WellNow Urgent Care, offering compounded semaglutide for weight loss. Claya is close behind and may still be the better fit — see the factor split below.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueLIV by WellNow +9
42
51
Dose & formulationClaya +2
75
73
Clinical oversightClaya +3
82
79
Labs & monitoringClaya +1
53
52
FulfillmentClaya +4
67
63
Contract termsClaya +6
61
55
Claya · left barLIV by WellNow · right bar

The numbers

MetricClayaLIV by WellNow
WeighScore62.8/10062.9/100
GradeCC
Scorecard rank#264#262
Semaglutide$299/mo (compounded)$279/mo
Tirzepatide$299/mo (compounded)Not disclosed
CoverageCoverage not published5 states
Brand-name accessCompounded onlyYes
Oral / sublingualYesInjection only
Claya

Graded #264 · C

Strengths

  • Two named licensed clinicians (Habashy, NMD MS and Barber, MD PhD) — rare transparency for compounded GLP-1
  • Two named pharmacy partners with full addresses (RedRock, UT and Healthware, KY)
  • Both injectable and oral-tablet forms offered for semaglutide and tirzepatide
  • Weight-loss money-back guarantee published on the homepage
  • Free expedited shipping included in the monthly price

Where it loses points

  • States-served list not disclosed — you must check at checkout
  • LegitScript certification status not displayed
  • Corporate legal entity not disclosed on the site or privacy policy
  • Oral compounded tablets have weaker efficacy data than injectable semaglutide
  • Intro pricing is higher at refill ($299), erasing the first-month advantage
LIV by WellNow

Graded #262 · C

Strengths

  • Flat $279/month covers medication, supplies, and unlimited virtual visits
  • Backed by established WellNow Urgent Care brand
  • Board-certified online medical providers
  • Same-day approval and monthly home delivery
  • Transparent all-inclusive pricing with no hidden fees

Where it loses points

  • Compounded semaglutide is not FDA-approved or evaluated
  • Only available in five states (IL, IN, MI, NY, PA)
  • No tirzepatide option offered
  • Insurance not accepted for compounded semaglutide

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard